author-photo

Charles E. Geyer

Houston Methodist Hospital

20

Papers

418

Citations

Citation Trend

Filter By

Papers (13) Sort By

Journal Conference Others

21-Gene Recurrence Score Predictive for Patients Most Likely to Benefit From Postoperative Radiation Following Breast Conserving Surgery for T1N0 Breast Cancer.

2021 International Journal of Radiation Oncology Biology Physics
Show All
- Source
- Cite
- Save
Citations (0)
Breast Cancer Index (BCI) and prediction of benefit from extended aromatase inhibitor (AI) therapy (tx) in HR+ breast cancer: NRG oncology/NSABP B-42.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
A phase II trial of stereotactic radiation therapy and in situ oncolytic virus therapy in metastatic triple-negative breast cancer (mTNBC) patients followed by pembrolizumab (STOMP).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Abstract OT-03-01: Trastuzumab deruxtecan (T-DXd; DS-8201) vs trastuzumab emtansine (T-DM1) in high-risk patients with HER2-positive, residual invasive early breast cancer after neoadjuvant therapy: A randomized, phase 3 trial (DESTINY-Breast05)

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Abstract 532: Association of pCR and the 8-gene signature: NRG Oncology/NSABP B-41

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Adjuvant T-DM1 versus Trastuzumab in Patients with Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer: Subgroup Analyses from KATHERINE.

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Analysis of the Implementation of Telehealth Visits for Care of Patients With Cancer in Houston During the COVID-19 Pandemic.

2020 Organic Process Research & Development
Show All
- Source
- Cite
- Save
Citations (28)
Race, ethnicity and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer in the randomized TAILORx trial.

2020 Journal of the National Cancer Institute
Show All
- Source
- Cite
- Save
Citations (14)
Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19).

2020 Reviews in Cardiovascular Medicine
Show All
- Source
- Cite
- Save
Citations (19)
Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancer.

2020 Cancer
Show All
- Source
- Cite
- Save
Citations (3)